Today I recorded a phone interview with Dr. Le Pool on her research that was just published in Science Translation Medicine. As you can see from the following articles, this is considered a very exciting breakthrough.
- Modified protein could become first effective treatment for vitiligo http://www.labspaces.net/127054/Modified_protein_could_become_first_effective_treatment_for_vitiligo
- Mutant protein offers promise of skin disease cure http://articles.chicagotribune.com/2013-03-13/health/ct-x-vitiglio-study-0313-20130313_1_vitiligo-immune-cells-protein
- Loyola researchers engineer protein to combat the skin disorder vitiligo http://news.medill.northwestern.edu/chicago/news.aspx?id=217259
- Modified Protein Could Become First Effective Treatment for Vitiligo Skin Disorder http://www.sciencedaily.com/releases/2013/02/130227150908.htm
- Understanding Disorder that Causes Skin to Lose Color Might Also Help in the Fight Against Deadly Skin Cancer http://loyolahealth.org/newswire/news/understanding-disorder-causes-skin-lose-color-might-also-help-fight-against-deadly
Here is the bio page for Dr. Le Poole at NVFI: http://www.nvfi.org/pages/bod_bio_le_poole.php
The audio recording of the interview is here: http://audio.edtechlive.com/vitiligocarolinelepoole.mp3. Please accept my apologies for the degrading quality of the audio as the interview goes along. I am in rural Australia traveling, and used Skype to call Dr. Le Poole, and the connection started out strong but you will find times when the quality if frustrating. Sorry. However, you should be able to make most of what she says out.
In an email reply to me, Dr. Le Poole had this to say: "
I didn't mean to downplay our findings, but rather wanted to emphasize that it will be a while until we can apply our technology to human patients. I don't want to instill what may be false hope, even though I have plenty of it myself. I'd like to mention that the full article can now be accessed via my Oncology Institute webpage at http://www.stritch.luc.edu/oncology_institute/node/13, for those interested in further information. Thanks for the opportunity to share our findings through the Vitiligo Friends network."
Replies
I called Dr. Le Poole last year, 2020 before the Coronavirus became a much bigger problem than it should have been. She told me that she will call me if I get selected. It was my dermatologist who recommended that I call her. Unfortunately, I wasn't selected.
Thank you for sharing!
I just saw a summary from Dr. Harris (researcher from Yale on vit cure with Tofacitinib) and he mentions that at fórum in California past month, results on HSp70 look 10 or 20 years away.
Back in 2013 when the news on HSP70 came out i wrote Dr. le Poole and she had mentioned about 2 years to be doing human trials, but with this information we are back to "nothing works. Sorry for the bad news,
Any news on this , please update.Its been 2 and half years,,,,is there no improvement at all or was it all fake.
We viligans need hope to live. Someone please update on this. We are all waiting.
I agree, my Dermatologist said that this study comes up every few years and there is no new news. I have emailed this doctor on several occasions and have asked for updates and nothing! I hope this isn't some cruel hoax or fundraising scam. I can share some news. My Vitiligo has spread on my legs and arms. I started to get it on my face around my eyes and lips. My doctor prescribed Protopic and my face responded well. It halted the Vitiligo and even reversed it. I am grateful for that but unfortunately, this is the only place that it has worked.We should have a forum where real success stories are posted so we all can learn from it. Unfortunately, we still get bombarded with make-up ads and con artists trying to sell junk.
My guess is that Mutant HSP70i was a fundraising scam indeed.
As a matter of fact, HSP70i is a protein that reverts a certain induced hipopigmentation (not non-segmental vitiligo). Those mice were ordered by Le Poole from a Lab. She ordered them already genetically modified with a certain hipopigmentation. So, the Mutant protein HSP70i reversed the mice's genetic modification that was known in advance.
The mice did not have vitiligo, but a known genetic hipopigmentation.
The theory worked, but it does not apply to vitiligo.